Teikoku Pharma granted FDA Fast Track Designation for TPU-006, a Novel 4-day Dexmedetomidine Transdermal System for Post Operative Pain Management

/PRNewswire/ -- Teikoku Pharma USA, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track...

Related Keywords

United States ,Japan ,California ,America ,Prnewswire Teikoku Pharma ,Paul Mori ,Teikoku Pharma ,Teikoku Seiyaku Co Ltd ,Teikoku Pharma United States Inc ,Drug Administration ,Pharma United States ,Fast Track Designation ,Chief Executive Officer ,Fast Track ,Accelerated Approval ,Priority Review ,Teikoku Pharma United States ,San Jose ,Latin America ,Docetaxel Alcohol Free ,Teikoku Pharma Usa ,Nc ,